认知行为疗法（Cognitive Behavioral Therapy for Insomnia，CBT-I）被认为是治疗失眠的首选一线疗法，近年来有研究探索将其与 CPAP 联合或在 CPAP 治疗前使用的效果，但对于 CBT-I 能否改善 CPAP 依从性尚未达成一致。还有一种治疗思路是在 CBT-I 基础上联合药物治疗，这种联合疗法在单纯失眠患者中进行了多项随机对照试验（Randomized ...

Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 ...

Nyxoah (NYXH) announced an update on the FDA approval process for the Genio system. On March 26, the company announced that the FDA issued an ...

The increasing prevalence of these conditions globally is fueling the demand for advanced MRI compatible patient monitoring ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

Floaters” are bits of cellular debris in the vitreous humor, which is the gel-filled space in between the lens and the retina.

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...

Taking a pill feels easier than addressing lifestyle factors, such as poor diet or sleep. But in many cases, the claims ...